Safety and feasibility of a new psychotherapeutic intervention for secured acute psychiatric wards – MCT-A

Not Applicable

• Conditions: F20-F29; F30-F39; F60-F69; F10-F19; F40-F48; F50-F59; F90-F98; F00-F09; Schizophrenia, schizotypal and delusional disorders; Mood [affective] disorders

• Registration Number: DRKS00020551
• Lead Sponsor: niversitätsklinikum Hamburg-Eppendorf Klinik und Poliklinik für Psychiatrie und PsychotherapieArbeitsgruppe Klinische Neuropsychologie

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2020-02-04
• Study Completion: 2021-09-01
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 77

Inclusion Criteria

Presence on a secured, closed acute psychiatric ward; diagnosis of a severe psychiatric illness (F diagnosis according to ICD-10)

Exclusion Criteria

Inability to give informed consent / no consent from the legal guardian, lack of German language skills, mental retardation, and dementia

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall satisfaction with and subjective utility of the intervention (self-generated questionnaire); measured after 2 and after 4 weeks, i.e. when participants have participated in up to 4 and up to 7 modules respectively.